Marco Herold
Has grant
Chief Executive Officer
AustraliaResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Marco Herold is the Chief Executive Officer at the Olivia Newton-John Cancer Research Institute in Australia. His research focuses on immunology and cancer biology, as reflected in his recent articles exploring topics such as TNFR signaling in immune responses, the role of IL-1β in SARS-CoV-2-induced disease, and the implications of CRISPR technology in urological cancers. He has contributed significantly to understanding B-cell development, as well as viral pathogenesis and cancer therapies.
Recent Grants
Grant: Close
FINDING NEW AVENUES TO OVERCOME CHEMORESISTANCE FOR IMPROVED CANCER THERAPY
Open Date: 2019-01-01
Close Date:
Grant: Close
The mutagenic influence of 5-methylcytosine and its relevance for cancer treatment
Open Date: 2018-01-01
Close Date: 2021-12-31
Grant: Close
Elucidating the cellular processes that are critical for p53 mediated tumour suppression
Open Date: 2018-01-01
Close Date: 2021-12-31
Grant: Close
Examining the contribution of mutant DNMT3a in the development and sustained growth of Acute Myeloid Leukaemia
Open Date: 2018-01-01
Close Date: 2020-12-31
Grant: Close
Toward effective targeted therapies for Acute Myeloid Leukaemia (AML)
Open Date: 2017-01-01
Close Date: 2019-01-01
Articles (10)
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (6)
Stefanie Mendes Bader
Walter and Eliza Hall Institute of Medical Research
Marc Pellegrini
Head
Walter and Eliza Hall Institute of Medical Research
james vince
Walter and Eliza Hall Institute of Medical Research
Martin Pal
Charles Sturt University
Wern Hann Ng
National University of Singapore
Marcus Robinson
MONASH UNIVERSITY
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.